DoseFinding
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
A side-by-side editorial comparison of pharmaverseadam and sdtm.oak — release velocity, themes, recent moves, and the top alternatives to consider.
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
Two releases in, the open-source SDTM toolkit now covers the domains it originally excluded.
sdtm.oak builds SDTM datasets — the tabulation standard clinical trial submissions are filed in — from raw collected data. The 0.1.0 release shipped the mapping algorithm functions and derived-variable helpers but explicitly excluded DM, trial design domains, and several others. Version 0.2.0 closes the largest of those gaps, adding DM domain support via calc_min_max_date() and oak_calc_ref_dates(), plus generate_sdtm_supp() for supplemental qualifier domains.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
sdtm.oak builds SDTM datasets — the tabulation standard clinical trial submissions are filed in — from raw collected data. The 0.1.0 release shipped the mapping algorithm functions and derived-variable helpers but explicitly excluded DM, trial design domains, and several others. Version 0.2.0 closes the largest of those gaps, adding DM domain support via calc_min_max_date() and oak_calc_ref_dates(), plus generate_sdtm_supp() for supplemental qualifier domains.
This is the pharmaverse pattern of building submission tooling in the open, one domain class at a time, with the release history running through GitHub release-candidate tags before each CRAN submission. The direction is clear from the domain checklist: start with the mechanically simple Findings and Events domains, then work toward the ones with cross-dataset dependencies. DM and SUPP were the two that most often forced teams back to bespoke code.
The remaining exclusions from the 0.1.0 scope — trial design domains, SV, SE, RELREC and the EPOCH variable — are the obvious next targets, with EPOCH likely first since it depends on the reference dates 0.2.0 just added. Expect the same rhythm of release candidates ahead of each CRAN submission.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either pharmaverseadam or sdtm.oak.
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul took mocking back from webmockr and made it a property of the client itself
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
Six years since the last functional change, and Google renamed the service it wraps in the release before that
See all pharmaverseadam alternatives → · See all sdtm.oak alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
Both compete on the same themes — pharmaverse — within Analytics. pharmaverseadam and sdtm.oak are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. pharmaverseadam and sdtm.oak are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.
Top sdtm.oak alternatives in Analytics are ranked by recent ship velocity. Browse the "sdtm.oak alternatives" section above for the current picks, or visit /alternatives/sdtm-oak for the full list with editorial commentary on each.